592 Phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: part 1 results
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.